![conference banner](/images/conference-banner.jpeg)
Abstract
Background: In high-risk human papillomavirus (HR-HPV)-positive cervical cancer, E6-associated protein (E6AP), an E3 ubiquitin ligase, mediates the ubiquitination and proteasomal degradation of the tumor suppressor p53. Here, we addressed the question of whether caffeic acid phenethyl ester (CAPE), a natural product mainly derived from propolis, can disrupt the interaction between E6AP and p53, inhibit ubiquitination degradation of p53 and exhibit anti-cervical cancer activity.
Methods: The ability of CAPE to inhibit growth and to induce apoptosis was shown in HR-HPV-positive cervical cancer cell lines by performing CCK-8, colony formation and TUNEL assays. Apoptosis-related proteins were tested by western blotting. Coimmunoprecipitation, ubiquitination assay and protein stability assay were carried out to determine whether CAPE can disrupt the E6AP-p53 interaction and inhibit ubiquitination degradation of p53.
Results: Our results showed that CAPE inhibits the growth of HR-HPV-positive cervical cancer cells and induces the activation of apoptosis-related pathways. Importantly, CAPE inhibits E6AP expression and disrupts the interaction between E6AP and p53. It inhibits the ubiquitination of p53 and promotes its stabilization.
Conclusion: In summary, CAPE has a therapeutic effect on HPV-positive malignant cells, so further studies are needed to assess its clinical application.
[http://dx.doi.org/10.3390/cancers12051160] [PMID: 32380701]
[http://dx.doi.org/10.1016/j.ygyno.2009.09.006] [PMID: 19853287]
[http://dx.doi.org/10.1080/17460441.2018.1443074] [PMID: 29463131]
[http://dx.doi.org/10.1158/0008-5472.CAN-09-3307] [PMID: 20530688]
[http://dx.doi.org/10.1016/0092-8674(90)90409-8] [PMID: 2175676]
[http://dx.doi.org/10.1016/0092-8674(93)90384-3] [PMID: 8221889]
[http://dx.doi.org/10.1016/S1470-2045(01)00617-9] [PMID: 11905599]
[http://dx.doi.org/10.1371/journal.pone.0025981] [PMID: 22046250]
[http://dx.doi.org/10.1007/s10637-019-00848-7] [PMID: 31432292]
[http://dx.doi.org/10.1007/BF01941717] [PMID: 2450776]
[http://dx.doi.org/10.3390/biom11020176] [PMID: 33525407]
[http://dx.doi.org/10.1007/s00705-021-05107-w] [PMID: 34173062]
[http://dx.doi.org/10.1080/10408398.2013.821967] [PMID: 25365228]
[PMID: 23280020]
[http://dx.doi.org/10.1097/01.cad.0000224441.01082.bb] [PMID: 16926625]
[http://dx.doi.org/10.1269/jrr.45.253] [PMID: 15304968]
[http://dx.doi.org/10.1007/s10637-011-9667-8] [PMID: 21537887]
[http://dx.doi.org/10.1155/2016/3017108] [PMID: 26697130]
[http://dx.doi.org/10.3390/molecules22091554] [PMID: 28926932]
[http://dx.doi.org/10.1159/000159214] [PMID: 18824880]
[http://dx.doi.org/10.3390/molecules20059242] [PMID: 26007182]
[http://dx.doi.org/10.1371/journal.pone.0099631] [PMID: 24960186]
[http://dx.doi.org/10.3748/wjg.v12.i42.6779] [PMID: 17106925]
[http://dx.doi.org/10.1158/1940-6207.CAPR-12-0004-T] [PMID: 22562408]
[http://dx.doi.org/10.3390/cancers13133105] [PMID: 34206370]
[http://dx.doi.org/10.1038/cr.2017.132] [PMID: 29076503]
[http://dx.doi.org/10.1038/cr.2017.40] [PMID: 28322253]
[http://dx.doi.org/10.1016/j.redox.2019.101320] [PMID: 31526948]
[http://dx.doi.org/10.1186/1471-2091-9-S1-S4] [PMID: 19007434]
[http://dx.doi.org/10.1038/s41467-021-25390-0] [PMID: 34417460]
[http://dx.doi.org/10.1038/356215a0] [PMID: 1552940]
[http://dx.doi.org/10.1039/D0CS00163E] [PMID: 32869798]
[http://dx.doi.org/10.3390/ijms22136806] [PMID: 34202736]
[http://dx.doi.org/10.1038/sj.onc.1203013] [PMID: 10618705]
[http://dx.doi.org/10.1101/cshperspect.a000950] [PMID: 20457558]
[http://dx.doi.org/10.1038/nrc1455] [PMID: 15510160]
[http://dx.doi.org/10.1016/j.critrevonc.2020.103182] [PMID: 33276182]
[http://dx.doi.org/10.1128/MCB.01705-12] [PMID: 24820418]
[http://dx.doi.org/10.1158/0008-5472.CAN-14-1211] [PMID: 25172841]
[http://dx.doi.org/10.7555/JBR.27.20130030] [PMID: 23885265]
[http://dx.doi.org/10.1126/science.1092472] [PMID: 14704432]
[http://dx.doi.org/10.1073/pnas.98.3.1218] [PMID: 11158620]
[http://dx.doi.org/10.1182/blood-2011-10-387647] [PMID: 22689861]
[http://dx.doi.org/10.3390/cancers12082108] [PMID: 32751183]
[http://dx.doi.org/10.1128/mcb.13.8.4918-4927.1993] [PMID: 8393140]
[http://dx.doi.org/10.1038/onc.2016.159] [PMID: 27641331]
![Wayfinder Image](/images/wayfinder.jpg)